CTRI/2020/02/023126尚未招募3 期
Efficacy and safety of Equine rabies immunoglobulin (Equirab®) in WHO Category III exposure subjects treated for post-exposure prophylaxis of rabies: a prospective, single arm, non-comparative study
Bharat serums and Vaccines ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with Category III exposure to Rabies
排除标准
- •History of rabies vaccination
- •Known allergy to immunoglobulins
- •Suffering from a bleeding disorder
- •Receiving treatment with immunosuppressive agents
研究者
相似试验
Unknown
不适用
Effect of ERIG Injection on Day 7 After First Dose of Rabies Vaccination to Rabies Immune ResponseRabiesNCT03524417Queen Saovabha Memorial Institute20
已完成
1 期
Rabies G Protein Vaccine study for immunization against RabiesCTRI/2014/04/004538Cadila Pharmaceuticals Limited170
已完成
3 期
Immunogenicity and safety study of Rabies G protein Vaccine administered as a simulated post-exposure immunization in healthy volunteersCTRI/2016/08/007137Cadila Pharmaceuticals Limited800
进行中（未招募）
4 期
Effectiveness of rabies vaccine booster dose in animal handlers four hours after primary vaccinatioCTRI/2023/10/058429DR N R RAMESH MASTHI
进行中（未招募）
1 期
Study of Purified Vero Rabies Vaccine Compared with Two Reference Rabies Vaccines, Given in a Pre-exposure Regimen to Children and Adults and as Single Booster Dose to a Subset of AdultsRabiesMedDRA version: 20.0Level: PTClassification code 10037742Term: RabiesSystem Organ Class: 10021881 - Infections and infestationsEUCTR2019-000973-22-Outside-EU/EEASanofi Pasteur SA